| 摘要 |
FIELD: medicinal molecular biology, peptides, pharmacy. SUBSTANCE: invention relates to novel peptide sequences and their analogues showing properties of agonists of apolipoprotein A-1 (Apo-A-1) by their administration in effective doses to patient. Such analogues are used for treatment of different disorders associated with dyslipidemia. Invention comprises data about corresponding chemical structures, different complexes of such lipids, in part, with lipids as component pharmaceutical compositions and methods for treatment of dyslipidemic disorders. EFFECT: expanded assortment of agents in therapy of different dyslipidemic states. 51 cl, 10 tbl, 10 dwg
|
